Wyndgate Technologies(R) Division of Global Med Technologies(R), Inc. Surpasses 500 Site Milestone
October 20 2006 - 10:00AM
PR Newswire (US)
DENVER, Oct. 20 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R),
a division of Global Med Technologies(R), Inc., (OTC:GLOB)
(BULLETIN BOARD: GLOB) announced today that customers at more than
500 sites across the country have licensed its products. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
Wyndgate manufactures information management software for donor
centers and transfusion services. The Company's SafeTrace(R) donor
management system has been accepted by both large and small blood
centers as well as hospital-based donor centers. Wyndgate
additionally manufactures and sells its SafeTrace Tx(R) system, a
transfusion management system, which is also provided as the blood
bank solution accompanying full-suite laboratory information
systems from channel partner vendors. "In 2005, Global Med and
Wyndgate set their sights on reaching 500 customer sites. We are
pleased to announce that since 2005, we have successfully added
over 200 new sites to our growing customer base and met our
projected goal. Our next major milestone is 1,000 customer
installations," stated Michael I Ruxin, M.D., Chairman and CEO of
Global Med Technologies. Dr. Ruxin continued, "As anticipated, our
continued growth in the blood banking industry has resulted in
continued growth in our profits and the stability of our company.
This growth speaks to the strength of our pipeline, our ability to
close sales and the loyalty of our customers. This milestone is
truly a testament to the quality of Wyndgate's products, the
success of our Service 360(TM) commitment and the allegiance of our
customers." About Global Med Technologies, Inc. Global Med
Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Each year, Wyndgate's products and
services manage more than eight million blood components,
representing over 27% of the U.S. blood supply. Wyndgate's products
are being used in Canada and sub-Saharan Africa, and are being
implemented in the Caribbean. Together, the SafeTrace Tx(R)*
advanced transfusion management system and the SafeTrace(R) donor
management system provide Vein-to-Vein(R) tracking from donor
collection to patient transfusion. For more information about
Global Med's products and services, please call 800-WYNDGATE or
visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000 Web site: http://www.globalmedtech.com/
Copyright